Supplementary Figure 1:
Transcriptome of cancer-associated metabolic genes shows altered metabolic profile of SDH-mutated tumours. Gene expression data from 186 PCC/PGL that were profiled on the HG-U133 Plus 2.0 Affymetrix GeneChip were evaluated for a list of 2556 genes that encode for metabolic enzymes and transporters, adapted from the list reported by Possemato et al. 581 genes were differentially expressed (adjusted p value <0.01; Bonferroni multiple test comparisons): 300 upregulated and 281 downregulated in SDH-mutated tumours vs SDH WT mutated tumours. Heatmap shows classification using the 200 differentially expressed genes (40 upregulated and 160 downregulated) with a fold change >1.7. Supplementary Figure 2 a) Abundance of glycine, isoleucine leucine, proline, serine and valine in imCC Sdhb-null (KO c6 and c8) cells relative to wild-type (WT) control, as assessed using GC-MS (n=3, mean +/-SD). Serine is significantly decreased, while glycine and proline are increased, only in clone 8 b) Steady-state KG, alanine, fumarate, glycine, malate, proline and serine in SDH-mutated patient tumours (n=3) compared to SDH WT tumours (n=3). Data are mean +/-SD. As in KO cells, serine is significantly decreased, in SDHmutated tumours. Data are mean+/-SD c) genotyping of the mouse adrenal fibroblast Sdhb knockout cell line (MAF KO) shows homozygous deletion of Sdhb exon 2 (ex2) resulting in d) complete loss of SDHB protein expression. e) Steady-state concentrations of succinate are increased in cells and in the medium from SDH-deficient imCC and MAF (n=3, mean +/-SD). 
